Wed, May 26, 2021

Drew Ranieri Maintained (TMCI) at Hold with Increased Target to $32 on, May 26th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-32-on-may-26th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Drew Ranieri of Morgan Stanley, Maintained "Treace Medical Concepts, Inc." (TMCI) at Hold with Increased Target from $30 to $32 on, May 26th, 2021.

Drew has made no other calls on TMCI in the last 4 months.



There are 3 other peers that have a rating on TMCI. Out of the 3 peers that are also analyzing TMCI, 0 agree with Drew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Drew


  • Richard Newitter of "SVB Leerink" Initiated at Buy and Held Target at $38 on, Monday, May 24th, 2021
  • Rick Wise of "Stifel" Initiated at Strong Buy and Held Target at $35 on, Tuesday, May 18th, 2021
  • Robbie Marcus of "JP Morgan" Initiated at Buy and Held Target at $37 on, Tuesday, May 18th, 2021